Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA ADVANCED ENZYME TECHNOLOGIES VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x -6.0 27.9 - View Chart
P/BV x 1.7 3.1 52.8% View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 VISTA PHARMA   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    VISTA PHARMA
Mar-23
ADVANCED ENZYME TECHNOLOGIES
Mar-23
VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs14328 4.4%   
Low Rs7225 2.9%   
Sales per share (Unadj.) Rs0.348.3 0.6%  
Earnings per share (Unadj.) Rs-1.59.3 -16.2%  
Cash flow per share (Unadj.) Rs-1.312.4 -10.8%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs8.1110.5 7.4%  
Shares outstanding (eoy) m37.56111.82 33.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x39.15.7 683.9%   
Avg P/E ratio x-6.929.8 -23.3%  
P/CF ratio (eoy) x-7.822.3 -35.0%  
Price / Book Value ratio x1.32.5 51.3%  
Dividend payout %053.8 -0.0%   
Avg Mkt Cap Rs m39330,939 1.3%   
No. of employees `000NANA-   
Total wages/salary Rs m51,148 0.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m105,406 0.2%  
Other income Rs m4255 1.6%   
Total revenues Rs m145,661 0.2%   
Gross profit Rs m-441,534 -2.9%  
Depreciation Rs m6350 1.8%   
Interest Rs m1235 34.9%   
Profit before tax Rs m-591,404 -4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2365 -0.6%   
Profit after tax Rs m-571,039 -5.5%  
Gross profit margin %-442.728.4 -1,559.8%  
Effective tax rate %3.626.0 14.0%   
Net profit margin %-563.919.2 -2,935.4%  
BALANCE SHEET DATA
Current assets Rs m2387,221 3.3%   
Current liabilities Rs m141776 18.2%   
Net working cap to sales %963.0119.2 807.7%  
Current ratio x1.79.3 18.1%  
Inventory Days Days207255 81.1%  
Debtors Days Days40,90268 60,378.3%  
Net fixed assets Rs m2966,884 4.3%   
Share capital Rs m75224 33.6%   
"Free" reserves Rs m23012,127 1.9%   
Net worth Rs m30612,351 2.5%   
Long term debt Rs m5278 66.4%   
Total assets Rs m53414,105 3.8%  
Interest coverage x-3.841.4 -9.3%   
Debt to equity ratio x0.20 2,684.6%  
Sales to assets ratio x00.4 4.9%   
Return on assets %-8.37.6 -109.5%  
Return on equity %-18.58.4 -220.4%  
Return on capital %-13.111.6 -112.7%  
Exports to sales %017.3 0.0%   
Imports to sales %07.8 0.0%   
Exports (fob) Rs mNA937 0.0%   
Imports (cif) Rs mNA420 0.0%   
Fx inflow Rs m0937 0.0%   
Fx outflow Rs m0420 0.0%   
Net fx Rs m0518 0.0%   
CASH FLOW
From Operations Rs m-171,404 -1.2%  
From Investments Rs m-13-2,982 0.4%  
From Financial Activity Rs m31-258 -12.1%  
Net Cashflow Rs m1-1,709 -0.1%  

Share Holding

Indian Promoters % 15.6 2.6 612.9%  
Foreign collaborators % 12.2 41.1 29.7%  
Indian inst/Mut Fund % 0.0 29.5 0.1%  
FIIs % 0.0 22.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.2 56.4 128.0%  
Shareholders   13,908 73,034 19.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VISTA PHARMA vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VISTA PHARMA vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period VISTA PHARMA ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day -2.83% -1.96% 1.18%
1-Month -22.19% -9.39% -0.75%
1-Year 28.28% 51.81% 61.82%
3-Year CAGR 4.50% -0.39% 18.16%
5-Year CAGR -11.60% 15.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the VISTA PHARMA share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of VISTA PHARMA hold a 27.8% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VISTA PHARMA and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, VISTA PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.0, and its dividend payout ratio stood at 53.8%.

You may visit here to review the dividend history of VISTA PHARMA, and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.